Bio-Rad Laboratories (BIO) Return on Capital Employed Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -621.00 |
| Dec 31, 2025 | -706.00 |
| Sep 30, 2025 | -55.00 |
| Jun 30, 2025 | 188.00 |
| Mar 31, 2025 | 242.00 |
| Mar 31, 2024 | -9,854.00 |
| Dec 31, 2023 | 803.00 |
| Sep 30, 2023 | 39.00 |
| Jun 30, 2023 | 4.00 |
| Mar 31, 2023 | 373.00 |
| Dec 31, 2022 | 591.00 |
| Sep 30, 2022 | 314.00 |
| Jun 30, 2022 | 368.00 |
| Mar 31, 2022 | 686.00 |
| Dec 31, 2021 | 412.00 |
| Sep 30, 2021 | -33.00 |
| Jun 30, 2021 | -35.00 |
| Mar 31, 2021 | 225.00 |
| Dec 31, 2020 | 242.00 |
| Sep 30, 2020 | -207.00 |
| Jun 30, 2020 | -237.00 |
| Mar 31, 2020 | -231.00 |
| Dec 31, 2019 | -171.00 |
| Sep 30, 2019 | -600.00 |
| Jun 30, 2019 | -610.00 |
| Mar 31, 2019 | -684.00 |
| Dec 31, 2018 | -776.00 |
| Sep 30, 2018 | -353.00 |
| Jun 30, 2018 | -434.00 |
| Mar 31, 2018 | -539.00 |
| Dec 31, 2017 | -606.00 |
| Sep 30, 2017 | -938.00 |
| Jun 30, 2017 | -1,025.00 |
| Mar 31, 2017 | -948.00 |
| Dec 31, 2016 | -1,066.00 |
| Sep 30, 2016 | -739.00 |
| Jun 30, 2016 | -727.00 |
| Mar 31, 2016 | -667.00 |
| Dec 31, 2015 | -774.00 |
| Sep 30, 2015 | -697.00 |